SIGN UPLog In

General

Financials

People

Founders
Employee Profiles

Activity

Recent News

Last deal

—

Amount

Corporate Round

Stage

05.07.2024

Date

3

all rounds

$241.81M

Total amount

date founded

Financing round

General

About Company
IASO Biotherapeutics develops cell therapies for cancer treatment.

Industry

Sector :

Subsector :

Keywords :

Also Known As

南京驯鹿医疗技术有限公司, 驯鹿医疗

founded date

01.01.2017

founders

Number of employees

251-500

Company Type

For Profit

Last funding type

Corporate Round

IPO status

Private

Description

The Nanjing-based biopharmaceutical company, IASO Biotherapeutics, specializes in the discovery, development, and commercialization of cell therapies for oncology. Their products target hematological, solid, and virus-associated tumors, providing healthcare providers with more effective treatment options for their patients.
Contacts

location

Nanjing, Jiangsu, China

Contact Email

Phone number

Website URL

http://www.iasobio.com/
Similar Companies
999
Anchiano Therapeutics
Anchiano TherapeuticsAnchiano is a clinical-stage biopharmaceutical company that develops novel cancer therapies.
Anchiano Therapeutics

Anchiano Therapeutics

Anchiano is a clinical-stage biopharmaceutical company that develops novel cancer therapies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Jerusalem, Israel

total rounds

3

total raised

$32.43M
Synergys Biotherapeutics
Synergys BiotherapeuticsSynergys Biotherapeutics develops antibody fusion biotherapeutics for cancer treatment.
Synergys Biotherapeutics

Synergys Biotherapeutics

Synergys Biotherapeutics develops antibody fusion biotherapeutics for cancer treatment.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Alamo, CA, USA
Resolve Therapeutics
Resolve TherapeuticsResolve Therapeutics is a private biotechnology company focused on developing a novel targeted biologic therapy for the treatment of lupus.
Resolve Therapeutics

Resolve Therapeutics

Resolve Therapeutics is a private biotechnology company focused on developing a novel targeted biologic therapy for the treatment of lupus.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Kirkland, WA, USA

total rounds

3

total raised

$8.88M
Panolos Bioscience
Panolos BiosciencePanolos Bioscience is a biotechnology company that develops multi-specific drugs for cancer treatment.
Panolos Bioscience

Panolos Bioscience

Panolos Bioscience is a biotechnology company that develops multi-specific drugs for cancer treatment.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Seongnam-si, Gyeonggi-do, South Korea

total rounds

1

total raised

$17.6M

Financials

Funding Rounds
4
3

Number of Funding Rounds

$241.81M

Money Raised

Their latest funding was raised on 05.07.2024. Their latest investor Innovent Biologics. Their latest round Corporate Round

Date 
Funding Round 
Investors 
Money Raised 
Lead 
05.07.2024
Corporate Round
1
—
Innovent Biologics
Innovent Biologics
17.01.2023
Series C
6
$73.81M
Local Amount - CNY 500M
—
16.09.2021
Series C
7
$108M
CDH Investments
CDH Investments
Innovent Biologics

Innovent Biologics

Innovent develops and manufactures innovative medicines for major diseases, with a focus on oncology.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Manufacturing, Pharmaceuticals

Location

Suzhou, Jiangsu, China

total rounds

6

total raised

$868.31M

count Of Investments

2
CDH Investments

CDH Investments

CDH Investments is an international alternative asset fund manager with over $2.0 billion of committed capital under management.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Finance

Location

Kowloon City District, Hong Kong

count Of Investments

248

count Of Exists

13
Co-Investors
Investors
15
3

Number of lead investors

15

Number of investors

Investor 
Lead 
Round 
Partners 
Innovent Biologics
Innovent Biologics
Yes
Corporate Round
—
Hongcheng Capital
Hongcheng Capital
No
Series C
—
EFung Capital
EFung Capital
No
Series C
—
Innovent Biologics

Innovent Biologics

Innovent develops and manufactures innovative medicines for major diseases, with a focus on oncology.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Manufacturing, Pharmaceuticals

Location

Suzhou, Jiangsu, China

total rounds

6

total raised

$868.31M

count Of Investments

2
Hongcheng Capital

Hongcheng Capital

Hongcheng Capital invests in early-stage companies in various high-tech industries.

Sector

General Industrials

Subsector

Diversified Industrials

Keywords

Financial Services, Finance

Location

Nanchang, Fuping County, Hebei, Baoding, Hebei, China, 073299

count Of Investments

4
EFung Capital

EFung Capital

Shenzhen EFUNG Investment Management Enterprise is a pioneering VC institution that invests in professional biomedical industries.

Sector

Open End and Miscellaneous Investment Vehicles

Subsector

Open End and Miscellaneous Investment Vehicles

Keywords

Biotechnology, Financial Services

Location

Shenzhen, Guangdong Province, China

count Of Investments

46

count Of Exists

1

People

Founders
1
Brian K. Hall
Brian K. Hall

Brian K. Hall

current job

IASO Biotherapeutics
IASO Biotherapeutics

organization founded

1
Brian K. Hall

Brian K. Hall

Employee Profiles
5
Alan Fu
Alan Fu

Alan Fu

Chief Financial Officer (CFO)

Chief Financial Officer (CFO)

Biao Zheng
Biao Zheng

Biao Zheng

Chief Scientific Officer

Chief Scientific Officer

Brian K. Hall
Brian K. Hall

Brian K. Hall

Co-Founder & Executive Vice President

Co-Founder & Executive Vice President

David HE
David HE

David HE

Chief Technology Officer and Executive Vice President

Chief Technology Officer and Executive Vice President

Wen Wang
Wen Wang

Wen Wang

CEO & CMO

CEO & CMO

Activity

Recent News
0